Companion Animal Welfare

Companion Cat Hyperthyroid Concurrent Cardiac

Managing cats with concurrent hyperthyroidism and primary cardiac disease requires careful treatment sequencing that protects cardiac function while controlling thyroid hormone excess.

Key Facts

Approximately 10-15% of hyperthyroid cats have primary hypertrophic cardiomyopathy independent of thyroid disease
Pre-treatment echocardiography is essential to characterise cardiac status before thyroid treatment
Cardiac medications including atenolol may be needed alongside hyperthyroid treatment
Sudden worsening of cardiac disease during hyperthyroid treatment requires immediate reassessment
Quality of life assessment prioritises managing the most welfare-impacting condition

Welfare Considerations

Cats with concurrent primary cardiac disease and hyperthyroidism face the most complex welfare management challenges in feline internal medicine. Treating hyperthyroidism may unmask or worsen primary HCM, while untreated hyperthyroidism causes progressive cardiac damage. Staged treatment with pre-treatment cardiac characterisation and close monitoring enables the most welfare-protective approach to these challenging concurrent conditions.

What You Can Do

Request echocardiography before initiating hyperthyroid treatment in cats with cardiac signs
Monitor for cardiac decompensation throughout hyperthyroid treatment initiation
Seek specialist cardiology input for cats with significant concurrent cardiac disease